Literature DB >> 26233425

Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders.

Heather K Lehman1.   

Abstract

Primary immune deficiencies are often associated with autoimmune disease due to the dysregulation of the immune system as a whole. In many immune deficiencies, lymphocytes may be present but dysfunctional, allowing for the development of excessive autoreactivity and resultant autoimmune disease. Autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy, autoimmune lymphoproliferative syndrome, immunodyregulation polyendocrinopathy enteropathy X-linked, IL-10/IL-10 receptor deficiencies, and PLCG2-associated antibody deficiency and immune dysregulation are disorders in which autoimmunity is a hallmark of the clinical disease presentation. In contrast, adaptive and innate immune deficiencies, which are typically defined by their infectious susceptibilities, can be associated with variable rates of autoimmune manifestations, predominantly autoimmune cytopenias. This review describes the immune dysregulation and autoimmune manifestations that may be encountered in various immune deficiencies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26233425     DOI: 10.1007/s11882-015-0553-x

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  65 in total

1.  Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome.

Authors:  S Lacroix-Desmazes; I Resnick; D Stahl; L Mouthon; T Espanol; J Levy; S V Kaveri; L Notarangelo; M Eibl; A Fischer; H Ochs; M D Kazatchkine
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

Review 2.  New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

Authors:  David T Teachey
Journal:  Curr Opin Pediatr       Date:  2012-02       Impact factor: 2.856

3.  Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.

Authors:  Aude Magerus-Chatinet; Bénédicte Neven; Marie-Claude Stolzenberg; Cécile Daussy; Peter D Arkwright; Nina Lanzarotti; Catherine Schaffner; Sophie Cluet-Dennetiere; Filomeen Haerynck; Gérard Michel; Christine Bole-Feysot; Mohammed Zarhrate; Isabelle Radford-Weiss; Serge P Romana; Capucine Picard; Alain Fischer; Frédéric Rieux-Laucat
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

4.  Population prevalence of diagnosed primary immunodeficiency diseases in the United States.

Authors:  J M Boyle; R H Buckley
Journal:  J Clin Immunol       Date:  2007-06-19       Impact factor: 8.317

5.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Jaakko Perheentupa
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

6.  Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency.

Authors:  Aileen C Cohen; Kari C Nadeau; Wenwei Tu; Vivian Hwa; Kira Dionis; Liliana Bezrodnik; Alejandro Teper; Maria Gaillard; Juan Heinrich; Alan M Krensky; Ron G Rosenfeld; David B Lewis
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 7.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

8.  Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.

Authors:  Marsilio Adriani; Joseph Aoki; Reiko Horai; Angela M Thornton; Akihiro Konno; Martha Kirby; Stacie M Anderson; Richard M Siegel; Fabio Candotti; Pamela L Schwartzberg
Journal:  Clin Immunol       Date:  2007-05-18       Impact factor: 3.969

9.  Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma.

Authors:  Marco Catucci; Maria Carmina Castiello; Francesca Pala; Marita Bosticardo; Anna Villa
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561

10.  C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.

Authors:  C A Ogden; A deCathelineau; P R Hoffmann; D Bratton; B Ghebrehiwet; V A Fadok; P M Henson
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  9 in total

1.  The plethora, clinical manifestations and treatment options of autoimmunity in patients with primary immunodeficiency.

Authors:  Hatice Ezgi Barış; Ayça Kıykım; Ercan Nain; Ahmet Oğuzhan Özen; Elif Karakoç-Aydıner; Safa Barış
Journal:  Turk Pediatri Ars       Date:  2016-12-01

2.  The Incidence and Prevalence of Common Variable Immunodeficiency Disease in Taiwan, A Population-Based Study.

Authors:  Chih-Wei Tseng; Kuo-Lung Lai; Der-Yuan Chen; Ching-Heng Lin; Hsin-Hua Chen
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

Review 3.  Unbalanced Immune System: Immunodeficiencies and Autoimmunity.

Authors:  Giuliana Giardino; Vera Gallo; Rosaria Prencipe; Giovanni Gaudino; Roberta Romano; Marco De Cataldis; Paola Lorello; Loredana Palamaro; Chiara Di Giacomo; Donatella Capalbo; Emilia Cirillo; Roberta D'Assante; Claudio Pignata
Journal:  Front Pediatr       Date:  2016-10-06       Impact factor: 3.418

4.  Phenotypical T Cell Differentiation Analysis: A Diagnostic and Predictive Tool in the Study of Primary Immunodeficiencies.

Authors:  Enrico Attardi; Silvia Di Cesare; Donato Amodio; Carmela Giancotta; Nicola Cotugno; Cristina Cifaldi; Maria Chiriaco; Paolo Palma; Andrea Finocchi; Gigliola Di Matteo; Paolo Rossi; Caterina Cancrini
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

Review 5.  Primary immune regulatory disorders: Undiagnosed needles in the haystack?

Authors:  Aisling M Flinn; Andrew R Gennery
Journal:  Orphanet J Rare Dis       Date:  2022-03-03       Impact factor: 4.123

6.  SBT (Composed of Panax ginseng and Aconitum carmichaeli) and Stigmasterol Enhances Nitric Oxide Production and Exerts Curative Properties as a Potential Anti-Oxidant and Immunity-Enhancing Agent.

Authors:  Na-Ra Han; Kyeoung-Cheol Kim; Ju-Sung Kim; Hi-Joon Park; Seong-Gyu Ko; Phil-Dong Moon
Journal:  Antioxidants (Basel)       Date:  2022-01-20

Review 7.  Primary immunodeficiency.

Authors:  Christine McCusker; Julia Upton; Richard Warrington
Journal:  Allergy Asthma Clin Immunol       Date:  2018-09-12       Impact factor: 3.406

8.  Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32.

Authors:  Peter Lehmkuhl; Magdalena Gentz; Andres Caballero Garcia de Otezya; Bodo Grimbacher; Hendrik Schulze-Koops; Alla Skapenko
Journal:  Cell Mol Immunol       Date:  2021-05-31       Impact factor: 11.530

9.  Rituximab and Abatacept Are Effective in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.

Authors:  Yulia Rodina; E Deripapa; O Shvets; A Mukhina; A Roppelt; D Yuhacheva; A Laberko; V Burlakov; D Abramov; G Tereshchenko; G Novichkova; Anna Shcherbina
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.